🇺🇸 FDA
Patent

US 8932846

Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins

granted A61KA61K2039/523A61K39/04

Quick answer

US patent 8932846 (Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins) held by The Regents of the University of California expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/523, A61K39/04